[68Ga]VMT-02

N/A

Report date: 2025/11/20 16:00:54

Base Information

Drug Name[68Ga]VMT-02
Drug Alias Name[68Ga]VMT-0268Ga-VMT02
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionRadionuclide imaging enhancersDiagnostic imaging enhancersPositron-emission tomography enhancers +[4] 
TargetsMelanocortin receptor 1
Therapy Area/IndicationsUveal melanomaSkin MelanomaMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerspective Therapeutics IncMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesPerspective Therapeutics IncMayo Clinic
Inactive CompaniesN/A
Active IndicationsUveal melanomaSkin MelanomaMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A